IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 12244 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Next article
  Previous article 
  Table of Contents
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (86 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

In This Article
   Article Tables

 Article Access Statistics
    PDF Downloaded204    
    Comments [Add]    
    Cited by others 6    

Recommend this journal


Year : 2006  |  Volume : 38  |  Issue : 3  |  Page : 211-212

In vivo efficacy of an antifungal fraction from Pallavicinia lyellii , a liverwort

Tropical Botanic Garden and Research Institute, Tropical Botanic Garden and Research Institute, Pacha-Palode, Thiruvananthapuram District, Kerala - 695562, India

Correspondence Address:
A Subramoniam
Tropical Botanic Garden and Research Institute, Tropical Botanic Garden and Research Institute, Pacha-Palode, Thiruvananthapuram District, Kerala - 695562
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0253-7613.25814

Rights and Permissions

How to cite this article:
Subhisha S, Subramoniam A. In vivo efficacy of an antifungal fraction from Pallavicinia lyellii , a liverwort. Indian J Pharmacol 2006;38:211-2

How to cite this URL:
Subhisha S, Subramoniam A. In vivo efficacy of an antifungal fraction from Pallavicinia lyellii , a liverwort. Indian J Pharmacol [serial online] 2006 [cited 2023 Sep 29];38:211-2. Available from: https://www.ijp-online.com/text.asp?2006/38/3/211/25814

Almost all the antifungal agents, currently in use, have toxic side effects and are relatively expensive. Therefore, there is an urgent need to determine the in vivo efficacy of the active fraction or the isolate from the liverwort. Therefore, in the present study, the efficacy of the active fraction against aspergillosis caused by A. fumigatus in immuno-compromised mice was studied. The active fraction was also subjected to short term general toxicity evaluation in mice. Mice were reared in the animal house facility of the institute and were fed with standard rodent pellets (Lipton and Co. Bangalore) and water, ad libitium . They were maintained under standard laboratory conditions, temperature (25-28oC), humidity (50-80%) and 12 h light/dark cycle.

The animal house and breeding facility has been registered with CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on Animals), Government of India and CPCSEA guidelines are followed (IAEC approval obtained).

Pallavicinia lyellii was collected with their rhizoid on sunny days of June, from the forests near Palode, Thiruvanantha-puram District, Kerala State. The plant was identified by a bryophyte taxonomist of TBGRI and a voucher specimen was deposited. The alcohol extract of the powder of P. lyellii was prepared and subjected to fractionation with n-hexane to obtain the active hexane fraction.[1] This fraction was used for in vivo efficacy and short term toxicity evaluation in mice.

To study short term toxicity, 4 groups of mice, each containing 6 male mice (20-25 g, body weight) were used. One group was kept as the control group and Groups 2, 3 and 4 received 100, 200 and 400 mg/kg of the active fraction, respectively. The drug was administered daily for 15 days (p.o.). The control group received 1% Tween 80 in an identical manner.

The behaviour of the animals was observed daily for one hour in the forenoon (10 to 11 a.m.) for 14 days. The behavioural parameters observed were convulsion, grooming, hyperactivity, sedation, loss of the writhing reflex, heart rate and respiratory rate. Initial and final body weights, water and food intake and state of stools were observed. The animals were killed on the 15th day. Hematological and serum biochemical parameters (glutamate pyruvate transaminase [GPT], glutamate oxaloacetate transaminase [GOT], urea, glucose, cholesterol, triglyceride and protein) were determined following standard methods.[1] Hemoglobin was measured using hemoglobinometer with comparison standards. Liver, spleen, kidneys and heart were dissected, weighed and observed for pathological and morphological changes. The peritoneal macrophages and total leucocytes were counted as described elsewhere.[3]

Mice are normally resistant to the oral or intra-peritoneal route of infection with Aspergillus sp and other fungi. This resistance can be reduced by cortisone treatment, which suppresses the immune function. Therefore, the mice were inoculated subcutaneously with a single dose of 5 mg of hydrocortisone (Samarth Pharma (P) Ltd, Mumbai) and intramuscularly with 30,000 units of long-acting penicillin 2 days before intraperitoneal A. fumigatus spore challenge.[2] The animals were challenged with different quantities (0.01, 0.1, 0.5, 1 and 2 million) of viable spores to determine the minimum number of spores required for 100% mortality. 0.1 million spores were found to be sufficient to kill the mice.

To determine anti Aspergillus fumigatus activity, 54 male mice weighing 20-25 g were divided into 9 groups of 6 mice in each group. One group was kept as normal control, without any treatment. Seven groups were treated with hydrocortisone and penicillin 48 h after hydrocortisone treatment, 6 groups were challenged with 10 5spores per mouse and one group was kept as (hydrocortisone and penicillin) control without spore challenge. Three groups of spore-challenged mice received different doses (25, 50 and 100 mg/kg) of the active n-hexane fraction of alcohol extract; daily for 10 days, p.o. and the 4th and 5th spore-challenged groups received 50 and 100 mg/kg (daily for 10 days, p.o. ketoconazole (Nizral, Janssen-Cilag Pharmaceuticals, Mumbai), respectively; and the 6th spore- challenged group received the vehicle (1% Tween 80) and served as control. (1% Tween 80 was used as a vehicle for both the herbal drug and ketoconazole). One group of normal mice also received the active fraction (100 mg/kg). Mortality was observed daily for 30 days.

In short term limited toxicity evaluation, the active fraction administration for 15 days did not influence any of the parameters studied, in any of the doses used. The active fraction also did not result in any change in general behaviour, body weight, stool state organ weight (liver, kidneys and spleen), food and water intake, hemoglobin, leucocyte count, peritoneal macrophage count, serum protein, urea, GPT, GOT, alkaline phosphatase, total cholesterol, triglyceride and glucose (data not given).

As shown in [Table - 1], the administration of 10 5 spores per mouse to hydrocortisone-treated mice resulted in 100% mortality within 6 days. The active fraction at a dose of 100 mg/kg, p.o. daily, starting from the day of fungal challenge, protected all the fungal-challenged mice. The antifungal activity was dose dependent. Lower dose (50 mg/kg) protected 4 out of 6 mice, while the lowest dose tried (25 mg/kg) was ineffective. The antifungal activity of the active fraction was comparable to the standard drug, ketoconazole.

The antifungal fraction from P. lyellii was found to be effective against aspergillosis-induced mortality in immuno-compromised mice. We have already shown the direct antifungal activity of the herbal drug against the fungus under in vitro conditions.[1] Further, there is no report on the immuno-modulatory activity of such liverworts. Therefore, the observed protection from aspergillosis-induced mortality is likely to be due to the antifungal activity. This herbal drug appears to be non toxic whereas the antifungal drugs in current use, including ketoconazole, have reported toxic side effects after prolonged use.

P. lyellii is distributed in India and the biomass can be easily obtained.[4], [5] Thus, P. lyellii is likely to be an attractive material for developing invaluable antifungal drugs.

  Acknowledgment Top

The authors acknowledge Dr.Ganeshan, Director, Tropical Botanic Garden and Research Institute (TBGRI) and late Dr. G. Sreekandan Nair, former Director, TBGRI, for their keen interest and encouragement in the course of this research work. The authors express their sincere thanks to G Santhosh Kumar, Animal House Technician, for providing technical assistance in the execution of animal experiments.

  References Top

1.Subhisha S, Subramoniam A. Antifungal activities of a steroid from Pallavicinia lyellii , a liverwort. Indian J Pharmacol 2005;37:304-8.  Back to cited text no. 1    
2.Sidransky H, Friedman L. The effect of antibiotic agents on experimental pulmonary aspergillosis. Am J Path 1959;35:169-83.   Back to cited text no. 2  [PUBMED]  
3.Subramoniam A, Rajasekharan S, Latha PG, Evans DA, Pushpangadan P. Immuno-modulatory and anti-tumour activities of Janakia arayalpathra. Fitoterapia 1996;57:140-4.  Back to cited text no. 3    
4.Srinivasan C. Distribution of hepaticae and anthocerotae in India. In: Chopra RN, editor. Topics in bryology. New Delhi: Allied Publishers Ltd; 1998. p. 53-85.  Back to cited text no. 4    
5.Subramoniam A, Subhisha S. Bryophytes of India: A potential source of anti-microbial agents. In: Khan IA, Khanum A, editors. Role of biotechnology in medicinal and aromatic plants. Vol.11. Hyderabad, India: Ukaaz Publications; 2005.  Back to cited text no. 5    


[Table - 1]

This article has been cited by
1 Bryophytes as a safeguard of fruits from postharvest fungal diseases: A Review
Supriya Joshi, Prerna Bhardwaj, Afroz Alam
Natural Resources for Human Health. 2022;
[Pubmed] | [DOI]
2 Bryo-Activities: A Review on How Bryophytes Are Contributing to the Arsenal of Natural Bioactive Compounds against Fungi
Mauro Commisso, Francesco Guarino, Laura Marchi, Antonella Muto, Amalia Piro, Francesca Degola
Plants. 2021; 10(2): 203
[Pubmed] | [DOI]
3 Antifungal Bryophytes: A Possible Role Against Human Pathogens and in Plant Protection
Abhijit Dey, Jitendra Nath De
Research Journal of Botany. 2011; 6(4): 129
[VIEW] | [DOI]
4 Protection of immunocompromised mice from fungal infection with a thymus growth-stimulatory component from Selaginella involvens, a fern
Gayathri, V., Asha, V.V., John, J.A., Subramoniam, A.
Immunopharmacology and Immunotoxicology. 2011; 33(2): 351-359
5 Protection of immunocompromised mice from fungal infection with a thymus growth-stimulatory component fromSelaginella involvens, a fern
V. Gayathri,V.V. Asha,J. Anil John,A. Subramoniam
Immunopharmacology and Immunotoxicology. 2011; 33(2): 351
[Pubmed] | [DOI]
6 Promising antifungal activities of Hyophila involuta, a moss
Subhisha, S., Subramoniam, A.
Biomedicine. 2007; 27(3): 117-122


Print this article  Email this article


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow